-
An outbreak of conjunctivitis caused by a macrolide resistant unencapsulated pneumococcus occurred among naval trainees who were receiving azithromycin as prophylaxis against atypical pneumonia.
-
Overall, caspofungin was at least as effective as liposomal amphotericin B for empiric therapy in persistently febrile neutropenic patients. Caspofungin therapy was associated with greater survival 7 days after the end of therapy, greater efficacy in treatment of baseline fungal infections, and it was better tolerated.
-
-
-
-
The latest evidence of the continuing emergence of a single predominant strain of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) comes from Atlanta, where hospital-based investigators found the so-called USA 300 clone is causing 90% of incoming skin and soft tissue infections.
-
New patient safety goals for 2005 by the Joint Commission on Accreditation of Healthcare Organizations include preventing patient falls and avoiding potentially fatal mix-ups with similarly named drugs.
-
An award-winning patient safety program at the University of Pittsburgh Medical Center in McKeesport, PA, includes a focus on preventing troublesome Clostridium difficile infections.
-
A multifaceted patient safety program that included a focus on infection control has garnered a Pittsburgh hospital a 2004 John M. Eisenberg Patient Safety and Quality Award. The awards are given out annually by the Joint Commission on Accreditation of Healthcare Organizations and the National Quality Forum.
-
The Centers for Disease Control and Prevention (CDC) has formed a partnership with Aventis Pasteur Inc. to distribute 22.4 million doses of unshipped influenza vaccine to identified areas of need throughout the United States.
